RxDoctor Payments Data

Regan Hill, MD

Obstetrics & Gynecology · Yulee, FLNPI 1679616957

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,639 of the $6,627 with a category attached, or 70.0%. Intuitive Surgical accounts for 91.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $6,187 and has fallen 96.7% since, to $203 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,627in general payments, 2019–2025

Across 34 payments — averaging $194.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Astellas Pharma US Inc$122
  • Hologic Sales And Service, LLC$100
  • Bayer$74
  • Myriad Women's Health, Inc.$47
  • Sumitomo Pharma America, Inc.$44
  • plus $195 from 10 others

What the payments were for

  • Travel & lodging$1,52823%
  • Food & beverage$4597%
  • Education$4,63970%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,627 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida →

Medicare billing

Part B allowed, 2024
$80,120
Medicare patients
307
Services billed
875

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol145$8,943
ImvexxyEstradiol12$4,453
Clobetasol Propionate41$2,025
ProgesteroneProgesterone, Micronized11$667
Estradiol (Once Weekly)Estradiol11$657
Oxybutynin Chloride ErOxybutynin Chloride33$341
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$264
Scopolamine22$257
Medroxyprogesterone Acetate24$247
Cephalexin16$227
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$224
Fluconazole24$186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$104
Ibuprofen24$97
Ciprofloxacin Hcl14$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Therapeuticsmd, Inc.Imvexxy$15$4,45312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.

Other obstetrics & gynecology in Yulee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →